/es
The Enlarged Board of Appeal of the European Patent Office issued the decision in referral G2/21 on 23 March 2023. This referral concerned the admissibility of post-published evidence in the assessment of inventive step.
Following an earlier dispute over a trademark relating to a certain caterpillar cake, Marks and Spencer PLC (M & S) and Aldi
The EPO are increasing their official fees on 1 April 2023. This fee increase is unusual in that the EPO has historically raised its fees every two years.
A recent decision from the EPO’s Technical Boards of Appeal (T2803/18) highlights a pitfall for applicants wishing to patent systems and methods
The EPO introduced the latest version of the Guidelines for Examination on 1 March 2023. Some of the revisions are highlighted below.
A recent decision from the EPO’s Boards of Appeal (T 0702/20) provides a practical example of where the boundary lies in terms of
After years of uncertainty in the timeline of the Unified Patent Court (UPC), it has just been announced that Germany will ratify
The European Patent Office (EPO) has recently ruled that patients in a clinical trial were not members of the public such that
The way of determining the compliance period of a UK divisional application is changing on 1 May 2023. From 1 May 2023
The EPO has recently issued a decision confirming that oral proceedings before examining divisions, the Legal Division, the Receiving Section and now,